Find policies, billing codes, payers, states, and providers
CPT 78730: Ureteral Reflux Study with Bladder Function Radioisotope Evaluation
CPT code 78730 denotes a combined diagnostic procedure that evaluates vesicoureteral reflux and bladder functional defects using a radioisotope during a ureteral reflux study. This mixed imaging and functional assessment matter nationally because it informs management of pediatric and adult patients with recurrent urinary tract infections, suspected reflux, or bladder dysfunction, and influences utilization of nuclear medicine services in outpatient and hospital settings. Key payers typically involved in coverage and payment decisions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn the clinical intent of the code, the typical care setting, and the scope of services captured by the code. The publication also summarizes common billing modifiers associated with this type of service, outlines where this procedure fits in clinical workflows, and highlights points payers commonly consider when adjudicating claims. Data not available in the input for associated taxonomies, specific ICD-10 diagnoses, related codes, and service-line financial benchmarks.
Customize your policy alerts
Sign up for cpt 78730 policy alerts
Get alerted when payer policies referencing 78730 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 78730 describes a diagnostic procedure in which a provider performs a ureteral reflux study while simultaneously using a radioisotope to evaluate functional defects in the urinary bladder. The procedure assesses both vesicoureteral reflux and bladder function by combining fluoroscopic or radionuclide reflux imaging with radionuclide assessment of bladder dynamics.
-
Service type: Nuclear medicine diagnostic study combined with urinary tract/voiding function assessment
-
Typical site of service: Hospital outpatient department or ambulatory imaging center